By inhibiting PDH, detached cancer cells steer glucose away from the TCA cycle, thereby reducing the production of mitochondrial ROS, limiting the cytotoxic effects of oxidative stress, and inducing resistance to anoikis, a form of programmed cell death in which cells detach from the extracellular matrix (ECM). Here, PDP1 is linked to cancer.